29 March 2021 in Proceedings of the National Academy of Sciences
MicroRNA-218 (miR-218) has been linked to several cognition related neurodegenerative and neuropsychiatric disorders. However, whether miR-218 plays a direct role in cognitive functions remains unknown. Here, using the miR-218 knockout (KO) mouse model and the sponge/overexpression approaches, we showed that miR-218-2 but not miR-218-1 could bidirectionally regulate the contextual and spatial memory in the mice. Furthermore, miR-218-2 deficiency induced deficits in the morphology and presynaptic neurotransmitter release in the hippocampus to impair the long term potentiation. Combining the RNA sequencing analysis and luciferase reporter assay, we identified complement component 3 (C3) as a main target gene of miR-218 in the hippocampus to regulate the presynaptic functions. Finally, we showed that restoring the C3 activity in the miR-218-2 KO mice could rescue the synaptic and learning deficits. Therefore, miR-218-2 played an important role in the cognitive functions of mice through C3, which can be a mechanism for the defective cognition of miR-218 related neuronal disorders. Significance Several neurodegenerative and neuropsychiatric disorders with cognitive symptoms show an abnormal expression of microRNA-218 (miR-218). In this study, we demonstrated that miR-218 regulated presynaptic functions and learning related behaviors through targeting the 3′-untranslated region (UTR) of the mRNA of complement component 3 (C3), a central component of the immune system. This finding may represent a common mechanism for the defective cognition of multiple neuronal disorders with miR-218 deficits and provide a strategy for the development of new therapy.
23 November 2020 in Proceedings of the National Academy of Sciences
Significance: Although synaptotagmin-7 (Syt7) has been found to play an important role in bipolar-like behavioral abnormalities in mice, the molecular mechanisms underlying the aberrant behaviors remain unknown. The reason for the promising efficacy of N -methyl- d -aspartate receptor (NMDAR) antagonists, such as ketamine, in the treatment of bipolar depression is also unclear. In the present study, we demonstrated that in human induced pluripotent stem cell-derived and mouse hippocampal neurons, Syt7 triggered glutamate release in the peripheral active zone, which efficiently activated juxtaposed postsynaptic GluN2B-NMDARs. As a result of the Syt7 deficits, GluN2B-NMDARs became hypoactive and consequently generated antidepressant effects, which induced mania-like behavioral abnormalities in the animals.
6 July 2021 in PLOS Biology
Synaptotagmin-7 (Syt7) plays direct or redundant Ca2+ sensor roles in multiple forms of vesicle exocytosis in synapses. Here, we show that Syt7 is a redundant Ca2+ sensor with Syt1/Doc2 to drive spontaneous glutamate release, which functions uniquely to activate the postsynaptic GluN2B-containing NMDARs that significantly contribute to mental illness. In mouse hippocampal neurons lacking Syt1/Doc2, Syt7 inactivation largely diminishes spontaneous release. Using 2 approaches, including measuring Ca2+ dose response and substituting extracellular Ca2+ with Sr2+, we detect that Syt7 directly triggers spontaneous release via its Ca2+ binding motif to activate GluN2B-NMDARs. Furthermore, modifying the localization of Syt7 in the active zone still allows Syt7 to drive spontaneous release, but the GluN2B-NMDAR activity is abolished. Finally, Syt7 SNPs identified in bipolar disorder patients destroy the function of Syt7 in spontaneous release in patient iPSC-derived and mouse hippocampal neurons. Therefore, Syt7 could contribute to neuropsychiatric disorders through driving spontaneous glutamate release.